Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline

Affiliations

• ¹ Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London, London, UK; Palliative Care Team, Central and North West London NHS Trust, London, UK.
• ² Marie Curie Charity, London, UK.
• ³ Academic Unit of Surgery, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.
• ⁴ Department of Medical Oncology, La Paz University Hospital, IdiPAZ, CIBERONC, Cátedra UAM-AMGEN, Madrid, Spain.
• ⁵ Departments of Palliative Care, Rehabilitation and Integrative Medicine, Houston, USA; General Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
• ⁶ Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK; St Columba's Hospice Care, Edinburgh, UK.
• ⁷ Medical Oncology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Specialised, Experimental and Diagnostic Medicine, University of Bologna, Bologna, Italy.
• ⁸ Health Education and Practices Laboratory (LEPS EA3412), University Paris Sorbonne Paris Cité, Bobigny, Paris, France.
• ⁹ Department of Palliative and Supportive Care, Palliative Care Team and Seirei Hospice, Seirei Mikatahara General Hospital, Shizuoka, Japan.
• ¹⁰ Palliative Care Supportive Team, Hospital Universitario Arnau de Vilanova, Lleida, Spain.
• ¹¹ Research Department of Primary Care and Population Health, University College London, London, UK.
• ¹² Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London, London, UK.
• ¹³ UOC Oncologia Medica Territoriale, La Sapienza University of Rome, Polo Pontino, Rome, Italy.
• ¹⁴ Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.